Radiopharmaceutical Therapy
Lifespan is the first and only center in the region to offer radiopharmaceutical therapy, an advanced treatment that targets specific cancer cells within the body. Radiopharmaceuticals are a compound that is administered by a multidisciplinary team consisting of a medical oncologist, a nuclear medicine physician, and advanced practice providers. This treatment is recommended for prostate cancer that is metastatic, resistant to hormone therapy, or resistant to chemotherapy.
Radiopharmaceutical therapy delivers radiation directly to cancer cells, limiting damage to healthy tissue. The drug is a bi-specific antibody consisting of radioactive atoms combined with a cancer cell-targeting molecule. When infused into the bloodstream, the radiopharmaceutical travels to and binds to targeted cancer cells, bringing the radiation directly to the tumor while limiting exposure to healthy tissue.
It is important to note that radiopharmaceuticals are not the first line of treatment for prostate cancer.
To learn more or schedule an appointment, please call 1-844-222-2881.